Binex Co (XKRX:053030) Debt-to-Asset : 0.24 (As of Dec. 2024)

View and export this data going back to 2001. Start your Free Trial

What is Binex Co Debt-to-Asset?

Binex Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩61,176 Mil. Binex Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₩4,873 Mil. Binex Co's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2024 was ₩279,388 Mil. Binex Co's debt to asset for the quarter that ended in Dec. 2024 was 0.24.

Binex Co Debt-to-Asset Historical Data

The historical data trend for Binex Co's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Binex Co Debt-to-Asset Chart

Binex Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Debt-to-Asset

Get a 7-Day Free Trial

0.21

0.19

0.21

0.24

Binex Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Asset	Get a 7-Day Free Trial															0.21	0.23	0.26	0.26	0.24

Competitive Comparison of Binex Co's Debt-to-Asset

For the Biotechnology subindustry, Binex Co's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Binex Co's Debt-to-Asset Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Binex Co's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Binex Co's Debt-to-Asset falls into.

Binex Co Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Binex Co's Debt-to-Asset for the fiscal year that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(61176.33	+	4873.304)	/	279388.274
	=	0.24

Binex Co's Debt-to-Asset for the quarter that ended in Dec. 2024 is calculated as

Debt-to-Asset	=	Total Debt			/	Total Assets
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Assets
	=	(61176.33	+	4873.304)	/	279388.274
	=	0.24

Binex Co (XKRX:053030) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.

Binex Co Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Binex Co's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Binex Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Binex Co Ltd (XKRX:053030) » Definitions » Debt-to-Asset

Comparable Companies

Traded in Other Exchanges

N/A

Address

480-2 Janglim-dong, Saha-gu, Busan, KOR, 604-846

Website

http://www.bi-nex.co.kr

Binex Co Ltd is engaged in manufacturing and distribution of pharmaceutical products. The key products include gastrointestinal (GI) tract regulators and antispasmodics, antiemetic drugs, antihistamines, laxatives, antihypertensive and urinary agents, antibacterial and antibiotic agents, cough and cold remedies, anti-diabetic medicines, ophthalmic solutions, vitamins, nutrients, as well as an ointment, creams, and others. It also manufactures biomedicines and raw materials. Its other business operation involved contract development and manufacturing business for other companies. The company invests in some bio ventures that develop biomedicines.

Binex Co Headlines

No Headlines